Penny Stocks To Buy [or Sell] #1: AIM ImmunoTech
AIM ImmunoTech (AIM – Download Report) is one of the more frequently discussed penny stocks right now. We started covering it back in January just as “coronavirus penny stocks” became a keyphrase. Since then, we’ve watched AIM stock jump from around $0.80 to highs of $3.40. While it pulled back from those highs, AIM has continued to trend in March.
On March 2, shares of the company jumped from around $1.65 to highs of $1.97. While there was no news to go along with it, recent interest in coronavirus stocks again could be a factor. On a broad level, the company works to develop treatments for viral and immune-based disorders. The company’s product, Ampligen was initially designed for a broad range of applications in anti-viral and anti-cancer properties.
Recently, however, the company has taken aim at Ampligen for its potential application for coronavirus. Last week the company reported that it joined with ChinaGoAbroad for an Ampligeen China Entry against COVID-19. AIM CEO Thomas K. Equels said in a press release, “Ampligen achieved a 100% survival rate, as compared to 100% mortality in the untreated control animals, in SARS animal experiments after the outbreak in 2003. In these experiments, Ampligen was administered to mice prior to and shortly after infection. The Company believes that Ampligen may provide similarly effective prophylaxis against COVID-19, as both coronaviruses are extremely similar in key regulatory RNA sequences essential for coronaviral replication.”